Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Franklin

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Trends in Plant Science|October 16, 2022
Altered cyclone-fire interactions are changing ecosystemsThomas Ibanez, William J Platt, Peter J Bellingham, et al.
Pediatric Blood & Cancer|August 6, 2008
Respiratory syncytial virus infections in children with acute myeloid leukemia: a report from the Children's Oncology GroupLillian Sung, Todd A Alonzo, Robert B Gerbing, et al.
The Lancet. Haematology|February 4, 2018
Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trialHagop M Kantarjian, Pierre Fenaux, Mikkael A Sekeres, et al.
Cancer|October 10, 2013
Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology GroupJason Canner, Todd A Alonzo, Janet Franklin, et al.
Pediatric Blood & Cancer|October 16, 2013
BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupAndrew S Moore, Todd A Alonzo, Robert B Gerbing, et al.
Blood|June 1, 2012
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology GroupMichael R Loken, Todd A Alonzo, Laura Pardo, et al.
Blood|March 2, 2012
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AMLJessica A Pollard, Todd A Alonzo, Michael Loken, et al.
American Journal of Botany|June 5, 2020
Subspecies differentiation in an enigmatic chaparral shrub speciesYi Huang, Glen R Morrison, Alan Brelsford, et al.
Pediatric Blood & Cancer|July 21, 2006
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942)Shana S Jacobs, Linda C Stork, Bruce C Bostrom, et al.
Asia-Pacific Journal of Clinical Oncology|June 29, 2021
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemiaYukio Kobayashi, Iekuni Oh, Toshihiro Miyamoto, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Trends in Plant Science|October 16, 2022
Altered cyclone-fire interactions are changing ecosystemsThomas Ibanez, William J Platt, Peter J Bellingham, et al.
Pediatric Blood & Cancer|August 6, 2008
Respiratory syncytial virus infections in children with acute myeloid leukemia: a report from the Children's Oncology GroupLillian Sung, Todd A Alonzo, Robert B Gerbing, et al.
The Lancet. Haematology|February 4, 2018
Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trialHagop M Kantarjian, Pierre Fenaux, Mikkael A Sekeres, et al.
Cancer|October 10, 2013
Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology GroupJason Canner, Todd A Alonzo, Janet Franklin, et al.
Pediatric Blood & Cancer|October 16, 2013
BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupAndrew S Moore, Todd A Alonzo, Robert B Gerbing, et al.
Blood|June 1, 2012
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology GroupMichael R Loken, Todd A Alonzo, Laura Pardo, et al.
Blood|March 2, 2012
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AMLJessica A Pollard, Todd A Alonzo, Michael Loken, et al.
American Journal of Botany|June 5, 2020
Subspecies differentiation in an enigmatic chaparral shrub speciesYi Huang, Glen R Morrison, Alan Brelsford, et al.
Pediatric Blood & Cancer|July 21, 2006
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942)Shana S Jacobs, Linda C Stork, Bruce C Bostrom, et al.
Asia-Pacific Journal of Clinical Oncology|June 29, 2021
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemiaYukio Kobayashi, Iekuni Oh, Toshihiro Miyamoto, et al.
Pageof 10